Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonel Trebicka

Showing results (391-400 of 512) with videos related to

Pageof 52
Sort By:
Molecular Metabolism|November 14, 2021
Targeting the cytoplasmic polyadenylation element-binding protein CPEB4 protects against diet-induced obesity and microbiome dysbiosisNuria Pell, Ester Garcia-Pras, Javier Gallego, et al.
JHEP Reports : Innovation in Hepatology|December 19, 2024
Quantification of alcohol intake in patients with steatotic liver disease and excessive alcohol intakeEmil Deleuran Hansen, Nikolaj Torp, Stine Johansen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 10, 2022
Early prediction of decompensation (EPOD) score: Non-invasive determination of cirrhosis decompensation riskAnnika R P Schneider, Carolin V Schneider, Kai Markus Schneider, et al.
Hepatology (Baltimore, Md.)|March 19, 2016
Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertensionJulien Bissonnette, Juan Carlos Garcia-Pagán, Agustín Albillos, et al.
Blood|December 8, 2009
Impaired fibrinolysis as a risk factor for Budd-Chiari syndromeJildou Hoekstra, Ana H C Guimarães, Frank W G Leebeek, et al.
Hepatology Communications|July 19, 2021
Elective Surgery but not Transjugular Intrahepatic Portosystemic Shunt Precipitates Acute-On-Chronic Liver FailureJohannes Chang, Avend Bamarni, Nina Böhling, et al.
The Lancet. Gastroenterology & Hepatology|April 9, 2019
Porto-sinusoidal vascular disease: proposal and description of a novel entityAndrea De Gottardi, Pierre-Emmanuel Rautou, Jeoffrey Schouten, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 4, 2025
The Vasopressin Biomarker Copeptin is Linked to Systemic Inflammation and Refines Prognostication in Decompensated CirrhosisLukas Hartl, Marlene Hintersteininger, Benedikt Simbrunner, et al.
Gut|April 4, 2020
Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensationSofia Monteiro, Josephine Grandt, Frank Erhard Uschner, et al.
Scientific Reports|June 21, 2018
The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic ratsPhilipp Schwabl, Ksenia Brusilovskaya, Paul Supper, et al.
Pageof 52

Showing results (391-400 of 512) with videos related to

Sort By:
Pageof 52
Molecular Metabolism|November 14, 2021
Targeting the cytoplasmic polyadenylation element-binding protein CPEB4 protects against diet-induced obesity and microbiome dysbiosisNuria Pell, Ester Garcia-Pras, Javier Gallego, et al.
JHEP Reports : Innovation in Hepatology|December 19, 2024
Quantification of alcohol intake in patients with steatotic liver disease and excessive alcohol intakeEmil Deleuran Hansen, Nikolaj Torp, Stine Johansen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 10, 2022
Early prediction of decompensation (EPOD) score: Non-invasive determination of cirrhosis decompensation riskAnnika R P Schneider, Carolin V Schneider, Kai Markus Schneider, et al.
Hepatology (Baltimore, Md.)|March 19, 2016
Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertensionJulien Bissonnette, Juan Carlos Garcia-Pagán, Agustín Albillos, et al.
Blood|December 8, 2009
Impaired fibrinolysis as a risk factor for Budd-Chiari syndromeJildou Hoekstra, Ana H C Guimarães, Frank W G Leebeek, et al.
Hepatology Communications|July 19, 2021
Elective Surgery but not Transjugular Intrahepatic Portosystemic Shunt Precipitates Acute-On-Chronic Liver FailureJohannes Chang, Avend Bamarni, Nina Böhling, et al.
The Lancet. Gastroenterology & Hepatology|April 9, 2019
Porto-sinusoidal vascular disease: proposal and description of a novel entityAndrea De Gottardi, Pierre-Emmanuel Rautou, Jeoffrey Schouten, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 4, 2025
The Vasopressin Biomarker Copeptin is Linked to Systemic Inflammation and Refines Prognostication in Decompensated CirrhosisLukas Hartl, Marlene Hintersteininger, Benedikt Simbrunner, et al.
Gut|April 4, 2020
Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensationSofia Monteiro, Josephine Grandt, Frank Erhard Uschner, et al.
Scientific Reports|June 21, 2018
The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic ratsPhilipp Schwabl, Ksenia Brusilovskaya, Paul Supper, et al.
Pageof 52